Have a feature idea you'd love to see implemented?
Let us know!
SLRN Acelyrin Inc
Price (delayed)
$6.15
Market cap
$613.82M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.84
Enterprise value
$486.14M
Highlights
Acelyrin's debt has decreased by 18% YoY and by 6% from the previous quarter
The EPS has surged by 90% year-on-year but it has declined by 19% since the previous quarter
SLRN's quick ratio has shrunk by 69% YoY and by 41% QoQ
SLRN's equity is down by 29% year-on-year and by 12% since the previous quarter
Key stats
What are the main financial stats of SLRN
Market
Valuations
Earnings
Shares outstanding
99.81M
Market cap
$613.82M
Enterprise value
$486.14M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.07
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$299.8M
EBITDA
-$299.31M
Free cash flow
-$210.49M
Per share
Balance sheet
Liquidity
EPS
-$2.84
Free cash flow per share
-$2.12
Book value per share
$5.74
Revenue per share
$0
TBVPS
$6.57
Total assets
$651.74M
Total liabilities
$83.52M
Debt
$1.07M
Equity
$568.22M
Working capital
$565.81M
Debt to equity
0
Current ratio
7.86
Quick ratio
7.71
Net debt/EBITDA
0.43
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-41.5%
Return on equity
-46.1%
Return on invested capital
-74.2%
Return on capital employed
-52.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SLRN stock price
How has the Acelyrin stock price performed over time
Intraday
-2.38%
1 week
1.15%
1 month
24.49%
1 year
-38.75%
YTD
-17.56%
QTD
24.75%
Financial performance
How have Acelyrin's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$375.33M
Net income
-$299.8M
Gross margin
N/A
Net margin
N/A
Acelyrin's operating income has decreased by 44% YoY and by 15% QoQ
SLRN's net income is down by 27% year-on-year and by 25% since the previous quarter
Growth
What is Acelyrin's growth rate over time
Valuation
What is Acelyrin stock price valuation
P/E
N/A
P/B
1.07
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 90% year-on-year but it has declined by 19% since the previous quarter
SLRN's equity is down by 29% year-on-year and by 12% since the previous quarter
Efficiency
How efficient is Acelyrin business performance
Acelyrin's return on equity has shrunk by 56% YoY and by 36% QoQ
SLRN's return on assets is down by 47% year-on-year and by 33% since the previous quarter
Acelyrin's return on invested capital has increased by 22% YoY but it has decreased by 10% QoQ
Dividends
What is SLRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SLRN.
Financial health
How did Acelyrin financials performed over time
The total liabilities has soared by 145% YoY and by 56% from the previous quarter
SLRN's quick ratio has shrunk by 69% YoY and by 41% QoQ
Acelyrin's debt is 100% less than its equity
SLRN's equity is down by 29% year-on-year and by 12% since the previous quarter
Acelyrin's debt has decreased by 18% YoY and by 6% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.